Health Care Systems Factors Affecting Breast Cancer Treatment Choices

Persistent Link:
http://hdl.handle.net/10150/156910
Title:
Health Care Systems Factors Affecting Breast Cancer Treatment Choices
Author:
Crane, Elizabeth
Issue Date:
Dec-2010
Publisher:
The University of Arizona.
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Abstract:
The purpose of this research was to explore and describe health care systems factors that influence treatment decisions for women with breast cancer in the United States (U.S.) and Norway. The specific aims of the study were to: (a) explore and describe how health care systems processes create barriers and facilitators of breast cancer treatment decisions for patients diagnosed with breast cancer in the US and Norway; and (b) compare and contrast the US and Norwegian system processes to identify advantages and disadvantages of each system as they relate to breast cancer treatments. A descriptive qualitative design was used to address the research aims and questions. Data were collected from key informants from the US and Norway. Content and matrix analysis were the primary descriptive and comparative approaches used for this study. First and second order matrices were created to display and analyze data obtained from key informant interviews. Findings indicate that financing allopathic care is a significant barrier for breast cancer patients within the US and financing CAM therapies are challenging in both countries. While allopathic treatment guidelines for breast cancer care are clearly outlined in both the US and Norway, both countries currently lack CAM treatment guidelines for use in this patient population, leading to inconsistent recommendations provided for patients. There are also significant barriers that prevent patient access of CAM providers, particularly by patients in an in-patient, hospital setting. Ultimately, when evaluating care and treatment plans for women diagnosed with breast cancer, health care providers should appreciate and acknowledge the significant system factors that may act as barriers or facilitators of care.
Type:
text; Electronic Thesis
Degree Name:
B.S.
Degree Level:
bachelors
Degree Program:
Honors College; Nursing
Degree Grantor:
University of Arizona

Full metadata record

DC FieldValue Language
dc.language.isoenen_US
dc.titleHealth Care Systems Factors Affecting Breast Cancer Treatment Choicesen_US
dc.creatorCrane, Elizabethen_US
dc.contributor.authorCrane, Elizabethen_US
dc.date.issued2010-12-
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.abstractThe purpose of this research was to explore and describe health care systems factors that influence treatment decisions for women with breast cancer in the United States (U.S.) and Norway. The specific aims of the study were to: (a) explore and describe how health care systems processes create barriers and facilitators of breast cancer treatment decisions for patients diagnosed with breast cancer in the US and Norway; and (b) compare and contrast the US and Norwegian system processes to identify advantages and disadvantages of each system as they relate to breast cancer treatments. A descriptive qualitative design was used to address the research aims and questions. Data were collected from key informants from the US and Norway. Content and matrix analysis were the primary descriptive and comparative approaches used for this study. First and second order matrices were created to display and analyze data obtained from key informant interviews. Findings indicate that financing allopathic care is a significant barrier for breast cancer patients within the US and financing CAM therapies are challenging in both countries. While allopathic treatment guidelines for breast cancer care are clearly outlined in both the US and Norway, both countries currently lack CAM treatment guidelines for use in this patient population, leading to inconsistent recommendations provided for patients. There are also significant barriers that prevent patient access of CAM providers, particularly by patients in an in-patient, hospital setting. Ultimately, when evaluating care and treatment plans for women diagnosed with breast cancer, health care providers should appreciate and acknowledge the significant system factors that may act as barriers or facilitators of care.en_US
dc.typetexten_US
dc.typeElectronic Thesisen_US
thesis.degree.nameB.S.en_US
thesis.degree.levelbachelorsen_US
thesis.degree.disciplineHonors Collegeen_US
thesis.degree.disciplineNursingen_US
thesis.degree.grantorUniversity of Arizonaen_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.